NCT00150046View on ClinicalTrials.gov

Efficacy and Safety of Everolimus in de Novo Heart Transplant Recipients

PHASE3CompletedINTERVENTIONAL
Enrollment

176

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

May 31, 2007

Conditions
Heart Transplantation
Interventions
DRUG

Everolimus

Trial Locations (2)

Unknown

Novartis Investigational Site, Germany

Basel Novartis Pharma AG, Basel

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY